This episode of five live focus on obesity, a major health concern in India, where approximately 40.3% adults are clinically prone to obesity. The discussion highlights the boundaries of the body mass index (BMI) as the only parameter to define votes, suggesting alternative methods such as waist-to-body percentage and body fat percentage. It also distinguishes between visible fat and intestine fats, emphasizing the latter dangers. This section investigates the emergence of anti-anti-organisms, including GLP-1, Banjaro, and Vigovi as an important drug advancement. An important point raised is the challenge to ensure that these drugs are properly used. It has been said that “The key here is that it is not a medicine that can be set up. Here you have to know when to start, how much to start and the important thing is when to stop.”